Cargando…
Comorbidity in lung cancer patients and its association with medical service cost and treatment choice in China
BACKGROUND: It is evident that comorbidity exacerbate the complexity of the management of lung cancer, however, limited research has been conducted to investigate the impact of comorbidity on health service utilization and cost, as well as the treatment choice among lung cancer patients. We examined...
Autores principales: | Ding, Ruoxi, Zhu, Dawei, He, Ping, Ma, Yong, Chen, Zhishui, Shi, Xuefeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092481/ https://www.ncbi.nlm.nih.gov/pubmed/32209058 http://dx.doi.org/10.1186/s12885-020-06759-8 |
Ejemplares similares
-
Comorbidity in lung cancer patients and its association with hospital readmission and fatality in China
por: Zhu, Dawei, et al.
Publicado: (2021) -
Comparison of health service use and costs in stroke with and without comorbidities: a cross-sectional analysis using China urban medical claims data
por: Ding, Ruoxi, et al.
Publicado: (2020) -
Medical Service Utilization and Direct Medical Cost of Stroke in Urban China
por: Zhu, Dawei, et al.
Publicado: (2020) -
Medical service utilisation and direct medical cost of depression: a cross-sectional analysis of urban medical claims data from China
por: Ding, Ruoxi, et al.
Publicado: (2022) -
Estimated annual prevalence, medical service utilization and direct costs of lung cancer in urban China
por: Zhu, Dawei, et al.
Publicado: (2021)